Low-dose Remifentanil to Suppress Haemodynamic Responses to Noxious Stimuli in Cardiac Surgery

孟勇,张利东,嵇晴,张转,曾琼,周志强,杨建军,段满林
DOI: https://doi.org/10.3969/j.issn.1008-8199.2008.05.014
2008-01-01
Abstract:Objective: To search for an optimal low dose of remifentanil that may cause fewer adverse events and effectively suppress haemodynamic responses to typical stressful stimuli.Methods: Sixty-eight patients(ASA≤Ⅲ) undergoing cardiac surgery were assigned to 4 dose groups(R1,R2,R3 and R4) and received total i.v.anaesthesia of constant administration of etomidate with continuous infusion of remifentanil at the dose of 0.1,0.2,0.3 or 0.4 μg/(kg·min),respectively.Subsequently,changes in MAP,HR,CI,SI,SVRI and ACI were recorded for 5 minutes.A 20% increase over the baseline in MAP and / or HR was considered to be of clinical significance,showing the patient to be a responder to noxious stimuli.And the brain information service(BIS) was monitored and directed to show the level of anesthesia.Results: CI,SI,SVRI,ACI and BIS values showed no significant differences among the four dose groups at different time points.There were fewer responders in the latter two groups(P0.05).Conclusion: Remifentanil at 0.3 or 0.4 μg/(kg·min) in combination with continuous infusion of etomidate in the pre-bypass period may mitigate potentially hazardous haemodynamic responses to stressful stimuli,which can be as effective as the higher doses of remifentanil reported in relevant literature.
What problem does this paper attempt to address?